Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Standard Biotools (LAB) Other Non Operating Income (2016 - 2026)

Standard Biotools has reported Other Non Operating Income over the past 16 years, most recently at $956000.0 for Q4 2025.

  • Quarterly Other Non Operating Income changed N/A to $956000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.8 million through Dec 2025, up 637.38% year-over-year, with the annual reading at $4.4 million for FY2025, 82.57% down from the prior year.
  • Other Non Operating Income was $956000.0 for Q4 2025 at Standard Biotools, down from $5.0 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $5.0 million in Q2 2025 and troughed at -$2.2 million in Q1 2024.
  • The 5-year median for Other Non Operating Income is $363500.0 (2021), against an average of $766571.4.
  • Year-over-year, Other Non Operating Income crashed 297.7% in 2024 and then surged 1104.61% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at $315000.0 in 2021, then tumbled by 62.22% to $119000.0 in 2022, then soared by 823.53% to $1.1 million in 2023, then tumbled by 62.51% to $412000.0 in 2024, then soared by 132.04% to $956000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Other Non Operating Income are $956000.0 (Q4 2025), $5.0 million (Q2 2025), and $3.9 million (Q1 2025).